메뉴 건너뛰기




Volumn 140, Issue 2, 2005, Pages 310-319

Identification of a new HLA-A*0201-restricted CD8+ T cell epitope from hepatocellular carcinoma-associated antigen HCA587

Author keywords

Cancer testis antigen; ELISPOT; Heptocellular carcinoma; Immunotherapy

Indexed keywords

CD8 ANTIGEN; EPITOPE; GAMMA INTERFERON; HCA587 ANTIGEN; HLA A ANTIGEN; PEPTIDE; TUMOR ANTIGEN; UNCLASSIFIED DRUG;

EID: 17644403571     PISSN: 00099104     EISSN: None     Source Type: Journal    
DOI: 10.1111/j.1365-2249.2005.02786.x     Document Type: Article
Times cited : (21)

References (45)
  • 1
    • 0033541491 scopus 로고    scopus 로고
    • Hepatocellular carcinoma
    • Schafer DE, Sorrell MF. Hepatocellular carcinoma. Lancet 1999; 353:1253-7.
    • (1999) Lancet , vol.353 , pp. 1253-1257
    • Schafer, D.E.1    Sorrell, M.F.2
  • 4
    • 0029924107 scopus 로고    scopus 로고
    • Human tumor antigens recognized by T lymphocytes
    • Boon T, van der Bruggen P. Human tumor antigens recognized by T lymphocytes. J Exp Med 1996; 183:725-9.
    • (1996) J Exp Med , vol.183 , pp. 725-729
    • Boon, T.1    Van Der Bruggen, P.2
  • 5
    • 0029992369 scopus 로고    scopus 로고
    • Efficient tumor eradication by adoptively transferred cytotoxic T-cell clones in allogeneic hosts
    • Toes RE, Kast WM, Blom RJ, Bakker SC, Offringa R, Melief CJ. Efficient tumor eradication by adoptively transferred cytotoxic T-cell clones in allogeneic hosts. Int J Cancer 1996; 66:686-91.
    • (1996) Int J Cancer , vol.66 , pp. 686-691
    • Toes, R.E.1    Kast, W.M.2    Blom, R.J.3    Bakker, S.C.4    Offringa, R.5    Melief, C.J.6
  • 6
    • 0030769148 scopus 로고    scopus 로고
    • Tumor eradication by wild-type p53-specific cytotoxic T lymphocytes
    • Vierboom MPM, Nijman HM, Offringa R et al. Tumor eradication by wild-type p53-specific cytotoxic T lymphocytes. J Exp Med 1997; 186:695-704.
    • (1997) J Exp Med , vol.186 , pp. 695-704
    • Vierboom, M.P.M.1    Nijman, H.M.2    Offringa, R.3
  • 7
    • 0141688283 scopus 로고    scopus 로고
    • Adoptive-cell transfer therapy for the treatment of patients with cancer
    • Dudley ME, Rosenberg SA. Adoptive-cell transfer therapy for the treatment of patients with cancer. Nature Rev Cancer 2003; 3:667-76.
    • (2003) Nature Rev Cancer , vol.3 , pp. 667-676
    • Dudley, M.E.1    Rosenberg, S.A.2
  • 8
    • 0030470404 scopus 로고    scopus 로고
    • Phase I clinical trial: T-cell therapy for prostate cancer using autologous dendritic cells pulsed with HLA-A0201-specific peptides from prostate-specific membrane antigen
    • Murphy G, Tjoa B, Ragde H, Kenny G, Boynton A. Phase I clinical trial: T-cell therapy for prostate cancer using autologous dendritic cells pulsed with HLA-A0201-specific peptides from prostate-specific membrane antigen. Prostate 1996; 29:371-80.
    • (1996) Prostate , vol.29 , pp. 371-380
    • Murphy, G.1    Tjoa, B.2    Ragde, H.3    Kenny, G.4    Boynton, A.5
  • 9
    • 0031941423 scopus 로고    scopus 로고
    • Vaccination of melanoma patients with peptide- or tumor lysate-pulsed dendritic cells
    • Nestle FO, Alijagic S, Gilliet M et al. Vaccination of melanoma patients with peptide- or tumor lysate-pulsed dendritic cells. Nat Med 1998; 4:328-32.
    • (1998) Nat Med , vol.4 , pp. 328-332
    • Nestle, F.O.1    Alijagic, S.2    Gilliet, M.3
  • 10
    • 0031890206 scopus 로고    scopus 로고
    • Immunologic and therapeutic evaluation of a synthetic peptide vaccine for the treatment of patients with metastatic melanoma
    • Rosenberg SA, Yang JC, Schwartzentruber DJ et al. Immunologic and therapeutic evaluation of a synthetic peptide vaccine for the treatment of patients with metastatic melanoma. Nat Med 1998; 4:321-7.
    • (1998) Nat Med , vol.4 , pp. 321-327
    • Rosenberg, S.A.1    Yang, J.C.2    Schwartzentruber, D.J.3
  • 12
    • 0026645959 scopus 로고
    • A nonapeptide encoded by human gene MAGE-1 is recognized on HLA-A1 by cytolytic T lymphocytes directed against tumor antigen MZ2-E
    • Traversari C, van der Bruggen P, Luescher IF, Lurquin C, Chomez P, Van Pel A. A nonapeptide encoded by human gene MAGE-1 is recognized on HLA-A1 by cytolytic T lymphocytes directed against tumor antigen MZ2-E. J Exp Med 1992; 176:1453-7.
    • (1992) J Exp Med , vol.176 , pp. 1453-1457
    • Traversari, C.1    Van Der Bruggen, P.2    Luescher, I.F.3    Lurquin, C.4    Chomez, P.5    Van Pel, A.6
  • 14
    • 0034020427 scopus 로고    scopus 로고
    • Definition of tumor-associated antigens in hepatocellular carcinoma
    • Stenner LF, Luo G, Sahin U et al. Definition of tumor-associated antigens in hepatocellular carcinoma. Cancer Epidemiol Biomarkers Prev 2000; 9:285-90.
    • (2000) Cancer Epidemiol Biomarkers Prev , vol.9 , pp. 285-290
    • Stenner, L.F.1    Luo, G.2    Sahin, U.3
  • 15
    • 0037100267 scopus 로고    scopus 로고
    • Large scale identification of human hepatocellular carcinoma-associated antigens by autoantibodies
    • Wang Y, Han KJ, Pang XW et al. Large scale identification of human hepatocellular carcinoma-associated antigens by autoantibodies. J Immunol 2002; 169:1102-9.
    • (2002) J Immunol , vol.169 , pp. 1102-1109
    • Wang, Y.1    Han, K.J.2    Pang, X.W.3
  • 16
    • 0028206046 scopus 로고
    • Isolation of naturally processed peptides recognized by cytolytic T lymphocytes (CTL) on human melanoma cells in association with HLA-A2.1
    • Wolfel T, Schneider J, Meyer Z et al. Isolation of naturally processed peptides recognized by cytolytic T lymphocytes (CTL) on human melanoma cells in association with HLA-A2.1 Int J Cancer 1994; 57:413-8.
    • (1994) Int J Cancer , vol.57 , pp. 413-418
    • Wolfel, T.1    Schneider, J.2    Meyer, Z.3
  • 17
    • 0028304337 scopus 로고
    • Identification of a peptide recognized by five melanoma-specific human cytotoxic T cell lines
    • Cox AL, Skipper J, Chen Y et al. Identification of a peptide recognized by five melanoma-specific human cytotoxic T cell lines. Science 1994; 264:716.
    • (1994) Science , vol.264 , pp. 716
    • Cox, A.L.1    Skipper, J.2    Chen, Y.3
  • 19
    • 0041469728 scopus 로고    scopus 로고
    • HCA587 antigen expression in normal tissues and cancers: Correlation with tumor differentiation in hepatocellular carcinoma
    • Li B, Qian XP, Pang XW et al. HCA587 antigen expression in normal tissues and cancers: correlation with tumor differentiation in hepatocellular carcinoma. Laboratory Invest 2003; 83:1185-92.
    • (2003) Laboratory Invest , vol.83 , pp. 1185-1192
    • Li, B.1    Qian, X.P.2    Pang, X.W.3
  • 20
    • 0033151591 scopus 로고    scopus 로고
    • The telomerase catalytic subunit is a widely expressed tumor-associated antigen recognized by cytotoxic T lymphocytes
    • Vonderheide RH, Hahn WC, Schultze JL, Naddler LM. The telomerase catalytic subunit is a widely expressed tumor-associated antigen recognized by cytotoxic T lymphocytes. Immunity 1999; 10:673-9.
    • (1999) Immunity , vol.10 , pp. 673-679
    • Vonderheide, R.H.1    Hahn, W.C.2    Schultze, J.L.3    Naddler, L.M.4
  • 21
    • 0030603987 scopus 로고    scopus 로고
    • Generation of mature dendritic cells from human blood. An improved method with special regard to clinical applicability
    • Romani N, Reider D, Heuer M et al. Generation of mature dendritic cells from human blood. An improved method with special regard to clinical applicability. J Immunol Meth 1996; 196:137-51.
    • (1996) J Immunol Meth , vol.196 , pp. 137-151
    • Romani, N.1    Reider, D.2    Heuer, M.3
  • 22
    • 3342925367 scopus 로고    scopus 로고
    • The Granzyme B ELISPOT assay: An alternative to the 51Cr-release assay for monitoring cell-mediated cytotoxicity
    • Shafer-Weaver KS, Sayers T, Strobl S et al. The Granzyme B ELISPOT assay: an alternative to the 51Cr-release assay for monitoring cell-mediated cytotoxicity. J Translat Med 2003; 1:14.
    • (2003) J Translat Med , vol.1 , pp. 14
    • Shafer-Weaver, K.S.1    Sayers, T.2    Strobl, S.3
  • 23
    • 0029043976 scopus 로고
    • Peptide binding to MHC class I molecules: Implications for antigenic peptide prediction
    • Parker KC, Shields M, DiBrino M et al. Peptide binding to MHC class I molecules: implications for antigenic peptide prediction. Immunol Res 1995; 14:34-57.
    • (1995) Immunol Res , vol.14 , pp. 34-57
    • Parker, K.C.1    Shields, M.2    DiBrino, M.3
  • 25
    • 0026732781 scopus 로고
    • Cationic lipids direct a viral glycoprotein into the class 1 major histocompatibility complex antigen-presentation pathway
    • Walker C, Selby M, Erickson A, Cataldo D, Valensi JP, Van Nest GV. Cationic lipids direct a viral glycoprotein into the class 1 major histocompatibility complex antigen-presentation pathway. Proc Natl Acad Sci USA 1992; 89:7915-8.
    • (1992) Proc Natl Acad Sci USA , vol.89 , pp. 7915-7918
    • Walker, C.1    Selby, M.2    Erickson, A.3    Cataldo, D.4    Valensi, J.P.5    Van Nest, G.V.6
  • 26
    • 0029912909 scopus 로고    scopus 로고
    • Expression of HLA class I molecules and the transporter associated with antigen processing in hepatocellular carcinoma
    • Kurokohchi K, Carrington M, Mann DL et al. Expression of HLA class I molecules and the transporter associated with antigen processing in hepatocellular carcinoma. Hepatology 1996; 23:1181-8.
    • (1996) Hepatology , vol.23 , pp. 1181-1188
    • Kurokohchi, K.1    Carrington, M.2    Mann, D.L.3
  • 27
    • 0003142849 scopus 로고    scopus 로고
    • Cancer/testis (CT) antigens - New link between gametogenesis and cancer
    • Old LJ. Cancer/testis (CT) antigens - new link between gametogenesis and cancer. Cancer Immunity 2001; 1:1-10.
    • (2001) Cancer Immunity , vol.1 , pp. 1-10
    • Old, L.J.1
  • 28
    • 0030890836 scopus 로고    scopus 로고
    • Cancer vaccines based on the identification of genes encoding cancer regression antigens
    • Rosenberg SA. Cancer vaccines based on the identification of genes encoding cancer regression antigens. Immunol Today 1997; 19:175-82.
    • (1997) Immunol Today , vol.19 , pp. 175-182
    • Rosenberg, S.A.1
  • 30
    • 0035721929 scopus 로고    scopus 로고
    • Specific cytotoxic T lymphocyte responses against Melan-A/MART1, tyrosinase and gp100 in vitiligo by the use of major histocompatibility complex/peptide tetramers: The role of cellular immunity in the etiopathogenesis of vitiligo
    • Palermo B, Campanelli R, Garbelli S et al. Specific cytotoxic T lymphocyte responses against Melan-A/MART1, tyrosinase and gp100 in vitiligo by the use of major histocompatibility complex/peptide tetramers: the role of cellular immunity in the etiopathogenesis of vitiligo. J Invest Dermatol 2001; 117:326-32.
    • (2001) J Invest Dermatol , vol.117 , pp. 326-332
    • Palermo, B.1    Campanelli, R.2    Garbelli, S.3
  • 32
    • 0034039974 scopus 로고    scopus 로고
    • MAGE-B5, MAGE-B6, MAGE-C2, and MAGE-C3: Four new members of the MAGE family with tumor-specific expression
    • Lucas S, Plaen ED, Boon T. MAGE-B5, MAGE-B6, MAGE-C2, and MAGE-C3: four new members of the MAGE family with tumor-specific expression. Int J Cancer 2000; 87:55-60.
    • (2000) Int J Cancer , vol.87 , pp. 55-60
    • Lucas, S.1    Plaen, E.D.2    Boon, T.3
  • 33
    • 0033965361 scopus 로고    scopus 로고
    • CT10: A new CT antigen homologous to CT7 and the MAGE family, identified by representational difference analysis
    • Gure AO, Stockert E, Arden KC et al. CT10: a new CT antigen homologous to CT7 and the MAGE family, identified by representational difference analysis. Int J Cancer 2000; 85:726-32.
    • (2000) Int J Cancer , vol.85 , pp. 726-732
    • Gure, A.O.1    Stockert, E.2    Arden, K.C.3
  • 34
    • 0033405438 scopus 로고    scopus 로고
    • Vaccination with MAGE-3A1 peptide-pulsed mature, monocyte- derived dendritic cells expands specific cytotoxic T cells and induceds regression of some metastases in advanced stage IV melanoma
    • Thurner B, Haendle I, Roder C et al. Vaccination with MAGE-3A1 peptide-pulsed mature, monocyte- derived dendritic cells expands specific cytotoxic T cells and induceds regression of some metastases in advanced stage IV melanoma. J Exp Med 1999; 190:1669-78.
    • (1999) J Exp Med , vol.190 , pp. 1669-1678
    • Thurner, B.1    Haendle, I.2    Roder, C.3
  • 35
    • 1642419534 scopus 로고    scopus 로고
    • Two new tumor-specific antigenic peptides encoded by gene MAGE-C2 and presented to cytolytic T lymphocytes by HLA-A2
    • Ma E, Germeau C, Vigneron N et al. Two new tumor-specific antigenic peptides encoded by gene MAGE-C2 and presented to cytolytic T lymphocytes by HLA-A2. Int J Cancer 2004; 109:698-702.
    • (2004) Int J Cancer , vol.109 , pp. 698-702
    • Ma, E.1    Germeau, C.2    Vigneron, N.3
  • 36
    • 0035500466 scopus 로고    scopus 로고
    • Combining computer algorithms with experimental approaches permits the rapid and accurate identification of T cell epitopes from defined antigens
    • Schirle M, Weinschenk T, Stevanovic S. Combining computer algorithms with experimental approaches permits the rapid and accurate identification of T cell epitopes from defined antigens. J Immunol Meth 2001; 257:1-16.
    • (2001) J Immunol Meth , vol.257 , pp. 1-16
    • Schirle, M.1    Weinschenk, T.2    Stevanovic, S.3
  • 37
    • 0036718859 scopus 로고    scopus 로고
    • Identification of a novel HLA-A*0201-restricted, cytotoxic T lymphocyte epitope in a human glioma-associated antigen, interleukin 13 receptor α2 chain
    • Okano F, Storkus WJ, Chambers WH, Pollack IF, Okada H. Identification of a novel HLA-A*0201-restricted, cytotoxic T lymphocyte epitope in a human glioma-associated antigen, interleukin 13 receptor α2 chain. Clin Cancer Res 2002; 8:2851-5.
    • (2002) Clin Cancer Res , vol.8 , pp. 2851-2855
    • Okano, F.1    Storkus, W.J.2    Chambers, W.H.3    Pollack, I.F.4    Okada, H.5
  • 38
    • 0034306972 scopus 로고    scopus 로고
    • Prostate stem cell antigen is a promising candidate for immunotherapy of advanced prostate cancer
    • Dannull J, Diener PA, Prikler L et al. Prostate stem cell antigen is a promising candidate for immunotherapy of advanced prostate cancer. Cancer Res 2000; 60:5522-8.
    • (2000) Cancer Res , vol.60 , pp. 5522-5528
    • Dannull, J.1    Diener, P.A.2    Prikler, L.3
  • 39
    • 0036558080 scopus 로고    scopus 로고
    • + T-cell epitope for the glycoprotein B homolog of human herpesvirus 8
    • + T-cell epitope for the glycoprotein B homolog of human herpesvirus 8. Blood 2002; 99:3360-6.
    • (2002) Blood , vol.99 , pp. 3360-3366
    • Wang, Q.J.1    Huang, X.L.2    Rappocciolo, G.3
  • 40
    • 0034033763 scopus 로고    scopus 로고
    • Quantification of Tumor-specific T lymphocytes with the ELISPOT assay
    • Schmittel A, Keilholz U, Thiel E, Scheibenbogen C. Quantification of Tumor-specific T lymphocytes with the ELISPOT assay. J Immunotherapy 2000; 23:289-95.
    • (2000) J Immunotherapy , vol.23 , pp. 289-295
    • Schmittel, A.1    Keilholz, U.2    Thiel, E.3    Scheibenbogen, C.4
  • 41
    • 0027973079 scopus 로고
    • The relationship between class I binding affinity and immunogenicity of potential cytotoxic T cell epitopes
    • Sette A, Vitiello A, Reherman B et al. The relationship between class I binding affinity and immunogenicity of potential cytotoxic T cell epitopes. J Immunol 1994; 153:5586-92.
    • (1994) J Immunol , vol.153 , pp. 5586-5592
    • Sette, A.1    Vitiello, A.2    Reherman, B.3
  • 42
    • 0033179885 scopus 로고    scopus 로고
    • Discrete proteolytic intermediates in the MHC class I antigen processing pathway and MHC I-dependent peptide trimming in the ER
    • Paz P, Brouwenstijn N, Perry R, Shastri N. Discrete proteolytic intermediates in the MHC class I antigen processing pathway and MHC I-dependent peptide trimming in the ER. Immunity 1999; 11:241-7.
    • (1999) Immunity , vol.11 , pp. 241-247
    • Paz, P.1    Brouwenstijn, N.2    Perry, R.3    Shastri, N.4
  • 43
    • 0033046472 scopus 로고    scopus 로고
    • Immunodominance in major histocompatibility complex class I-restricted T lymphocyte responses
    • Yewdell JW, Bennink JR. Immunodominance in major histocompatibility complex class I-restricted T lymphocyte responses. Annu Rev Immunol 1999; 17:51-8.
    • (1999) Annu Rev Immunol , vol.17 , pp. 51-58
    • Yewdell, J.W.1    Bennink, J.R.2
  • 44
    • 17644398661 scopus 로고    scopus 로고
    • Evaluating the cytotoxicity of innate immune effector cells using the GrB ELISPOT assay
    • Shafer-Weaver KA, Sayers T, Kuhns DB et al. Evaluating the cytotoxicity of innate immune effector cells using the GrB ELISPOT assay. J Transl Med 2004; 20 (2):31-8.
    • (2004) J Transl Med , vol.20 , Issue.2 , pp. 31-38
    • Shafer-Weaver, K.A.1    Sayers, T.2    Kuhns, D.B.3
  • 45
    • 0032534598 scopus 로고    scopus 로고
    • HLA-independent heterogeneity of CD81 T cell responses to MAGE-3, Melan-A/MART-1, gp100, tyrosinase, MC1R, and TRP-2 in vaccine-treated melanoma patients
    • Reynolds SR, Celis E, Sette A et al. HLA-independent heterogeneity of CD81 T cell responses to MAGE-3, Melan-A/MART-1, gp100, tyrosinase, MC1R, and TRP-2 in vaccine-treated melanoma patients. J Immunol 1998; 161:6970-6.
    • (1998) J Immunol , vol.161 , pp. 6970-6976
    • Reynolds, S.R.1    Celis, E.2    Sette, A.3


* 이 정보는 Elsevier사의 SCOPUS DB에서 KISTI가 분석하여 추출한 것입니다.